SCHEMBL7679337

SCHEMBL7679337

O=c1ccc(-c2ccccc2)nn1CCCN1CCNCC1c1cccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
MET P08581 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
SIGMAR1 Q99720 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681468 0.98 CREBBP (0.42) CREBBPKDM4EHTTGAAMAPT
SCHEMBL7681402 0.94 CREBBP (0.44) CREBBPKDM4EHTTGAAMAPT
SCHEMBL7681583 0.87 TAAR1 (0.40) PKMTAAR1
SCHEMBL7681450 0.85 TAAR1 (0.40) PKMSIGMAR1TAAR1
SCHEMBL7684227 0.81 TDP1 (0.39) PKMTAAR1
SCHEMBL8598453 0.79 NPC1 (0.42) KDM4ELMNAPKMKMT2ASMN1; SMN2
SCHEMBL8595853 0.77 NPC1 (0.42) KDM4ELMNAPKMKMT2ASIGMAR1
SCHEMBL6164922 0.74 HTR2A (0.45) TAAR1
SCHEMBL8597121 0.73 NPC1 (0.43) KDM4ELMNAPKMKMT2ASMN1; SMN2
SCHEMBL8597148 0.72 NPC1 (0.36) PKMKMT2ASIGMAR1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413966-B1 SEROTONERGIC AND CENTRAL DOPAMINERGIC ACTIVITY; AFFINITY FOR 5HT1A AND 5HT2 SEROTONIN AND D2 DOPAMINE RECEPTORS; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. 2002-07-02 US claimed
EP-1057820-A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) 2000-12-06 EP claimed